Yasushi Mio Selected Research

CP-532,903

1/2008

The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Mio Research Topics

Disease

4	Hypoxia (Hypoxemia) 03/2009 - 05/2007
3	Reperfusion Injury 01/2014 - 01/2008
2	Infarction (Infarctions) 03/2009 - 01/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2008 - 07/2006
2	Ischemia 01/2008 - 05/2007
1	Pain (Aches) 01/2022
1	Infections 04/2021
1	Delirium 04/2021
1	Urinary Tract Infections (Urinary Tract Infection) 04/2021
1	Myocardial Infarction 03/2009
1	Hypertension (High Blood Pressure) 07/2006
1	Critical Illness (Critically Ill) 07/2006
1	Cardiotoxicity 10/2004

Drug/Important Bio-Agent (IBA)

3	Adenosine Triphosphate (ATP)IBA 01/2014 - 05/2007
3	Anesthetics (Anesthetic Agents)IBA 01/2014 - 05/2007
2	Isoflurane FDA LinkGeneric 04/2008 - 05/2007
1	triphenyltetrazoliumIBA 03/2009
1	Glycogen Synthase Kinase 3 betaIBA 03/2009
1	WortmanninIBA 03/2009
1	Mitochondrial Permeability Transition PoreIBA 03/2009
1	XenonIBA 03/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2009
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2008
1	PotassiumIBA 01/2008
1	KATP ChannelsIBA 01/2008
1	CP-532,903IBA 01/2008
1	esmolol (Brevibloc)FDA LinkGeneric 07/2006
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 10/2004
1	Ropivacaine (Naropin)FDA LinkGeneric 10/2004

Therapy/Procedure

1	Catheters 01/2022
1	Indwelling Catheters (Indwelling Catheter) 04/2021
1	Urinary Catheters 04/2021
1	Perioperative Period 07/2006